Autobahn Therapeutics, Inc.
Biotechnology company · San Diego, California, United States
Autobahn Therapeutics, Inc. is a biotechnology company headquartered in San Diego, California, United States. It has reported private securities offerings to the US SEC, most recently $101 million sold in a notice filed in 2024.
Profile compiled from public records. Is this your company? Request a correction or update
Autobahn Therapeutics at a glance
Typebiotechnology company
HeadquartersSan Diego, California, United States
SEC CIK1815098
What does Autobahn Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $100.8 million sold (2024).
Frequently asked questions about Autobahn Therapeutics
Where is Autobahn Therapeutics headquartered?
Autobahn Therapeutics, Inc. is headquartered in San Diego, California, United States.
What does Autobahn Therapeutics do?
Autobahn Therapeutics, Inc. is a biotechnology company.
Similar companies
- BioAtla, Inc.San Diego, California, United States
- Neurocrine Biosciences IncSan Diego, California, United States
- ImmunityBio, Inc.San Diego, California, United States
- Sorrento Therapeutics, Inc.San Diego, California, United States
- Protego Biopharma, Inc.San Diego, California, United States
- Tempo Therapeutics, Inc.San Diego, California, United States
- Fate Therapeutics IncSan Diego, California, United States
- ImageneBio, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences